Procoagulant activity during coronary interventions and coronary artery patency.
D000077284:Abciximab; D015906:Angioplasty, Balloon, Coronary; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001777:Blood Coagulation; D003327:Coronary Disease / Q000503:physiopathology* / Q000628:therapy*; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D010974:Platelet Aggregation; D012008:Recurrence; D013917:Thrombin / Q000502:physiology; D013925:Thromboplastin / Q000502:physiology